An innovative cyanoacrylate device developed to improve the current standard of care for intravascular catheter securement

Abstract

Introduction: Over one billion intravascular devices are used worldwide, annually. Due to the associated complications with these devices, the development of a reliable yet cost-effective securement technique is extremely important. The purpose of this study is to demonstrate the strength of a novel catheter securement cyanoacrylate for securing peripheral venous catheters, central venous catheters, peripherally inserted central catheters, and all other intravascular catheter types. Materials and methods: An unprecedented in vitro method was performed to quantify and compare the strength of a novel cyanoacrylate product when securing intravascular catheters inserted into prepared porcine skin. In vivo, canine subjects were used to implant various types of catheters. These catheters were secured with a novel catheter securement cyanoacrylate to test the strength and durability while undergoing simulated clinical stresses. Results: In vitro, the catheter securement cyanoacrylate demonstrated superior strength over conventional catheter securement methods as well as other known cyanoacrylates. The catheter securement cyanoacrylate demonstrated the ability to maintain superior strength for up to 7 days. In vivo, the catheter securement cyanoacrylate demonstrated the ability to withstand five weight tugs per hour for a 3-h duration, alone, while securing three types of catheters in canine subjects. Conclusion: This is one of the first studies to provide quantitative data to support the use of cyanoacrylate for intravascular catheter securement. The results from this research suggest that the novel catheter securement cyanoacrylate can be a simple and cost-effective catheter securement device that can improve the current health care protocol for intravascular catheterization.

A Revolutionary, Proven Solution to Vascular Access Concerns: A Review of the Advantageous Properties and Benefits of Catheter Securement Cyanoacrylate Adhesives

“…The CSCAs were tested to prove the securement capabilities over a week-long period. The securement strength for CSCAs for securing Insyte Autoguard and Nexiva catheters at 7 days after initial securement was 16.36 N and 15.72 N, respectively 35…”

“…The study confirmed that SecurePortIV provides an effective sealant layer for the insertion site and a sufficient moisture barrier against aqueous solutions. The effective seal of SecurePortIV on the catheter insertion site may help reduce dressing changes 35,40. The 2021 Infusion Therapy Standards of Practice (the Standards ), which includes the additional option of TA use for stabilizing and securing VADs, now provides a better alternative for a catheter securement device that offers a full seal around the insertion site 24…”

“…According to Marsh et al, since securement CSCA products result in a reduction in catheter failure, the correlation between patient satisfaction and cost savings is “substantial.”34 Furthermore, Kleidon et al40 concluded that, since dressing changes are reduced using CSCAs, there is a potential for large savings in health care costs. The research conducted by Guido et al, using one CSCA, SecurePortIV in particular, concluded that the device is “simple and cost-effective,” which can “improve the current health care protocol.”35…”

“…As a result of this study, CSCAs were shown to result in a reduction of catheter failure rates by two thirds as compared to traditional standard care of practice. 34 In one study conducted by Guido et al, 35 CSCAs provided significant securement strength to secure 2 representative IV catheters, Insyte Autoguard (BD) and Nexiva (BD) catheters. In vitro studies were conducted to evaluate the securement strength of SecurePortIV when securing Insyte Autoguard and Nexiva IV catheters onto pig skin in the presence and absence of other catheter securement methods, Tegaderm (3M), HubGuard (Centurion Medical Products), Durapore (3M), and Opsite (Smith & Nephew).…”

“…The securement strength for CSCAs for securing Insyte Autoguard and Nexiva catheters at 7 days after initial securement was 16.36 N and 15.72 N, respectively. 35 A few of the studies that were reviewed indicated that there was no significant difference between catheter failures and migration rates when using CSCAs compared to various methods of securement such as a bordered or nonpolyurethane dressing or a securement device with or without a polyurethane dressing. [36][37][38] However, the majority of studies demonstrated that dislodgement and catheter migration rates were significantly lower with CSCAs than standard care.…”